Stay updated on Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe webpage has been updated to include new dates and a new biosimilar product, Pembrolizumab Biosimilar SB27, while previous dates and an older revision have been removed.SummaryDifference0.5%
- Check19 days agoChange DetectedThe webpage has undergone significant updates regarding the clinical trial for advanced Merkel cell carcinoma, including the removal of detailed trial objectives and descriptions, while adding new identifiers and a revision number.SummaryDifference20%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.SummaryDifference0.1%
- Check41 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 21, 2025, and version 2.14.2.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has updated its listings of cancer treatment facilities, replacing some locations with new ones while removing others. Additionally, there are updates to the dates mentioned on the page.SummaryDifference1%
- Check69 days agoChange DetectedThe web page has updated its date information, adding new dates for February 26 and February 27, 2025, while removing the earlier dates of February 5 and February 6, 2025.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.